IRIS
CALVISI, Diego Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.844
AS - Asia 5.300
SA - Sud America 3.332
EU - Europa 2.919
AF - Africa 210
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 15
Totale 20.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.600
BR - Brasile 3.017
SG - Singapore 2.479
CN - Cina 1.412
UA - Ucraina 963
HK - Hong Kong 518
DE - Germania 470
IT - Italia 387
SE - Svezia 296
VN - Vietnam 213
FI - Finlandia 183
GB - Regno Unito 156
CA - Canada 107
TR - Turchia 103
FR - Francia 97
AR - Argentina 91
IQ - Iraq 73
BD - Bangladesh 71
MX - Messico 69
EC - Ecuador 60
IN - India 60
RU - Federazione Russa 55
BE - Belgio 51
MA - Marocco 50
ZA - Sudafrica 50
PK - Pakistan 48
VE - Venezuela 48
UZ - Uzbekistan 44
AT - Austria 43
CZ - Repubblica Ceca 42
PL - Polonia 41
ES - Italia 40
ID - Indonesia 38
JP - Giappone 37
DZ - Algeria 33
CO - Colombia 32
PY - Paraguay 29
AU - Australia 26
AE - Emirati Arabi Uniti 20
NP - Nepal 20
JO - Giordania 19
AZ - Azerbaigian 18
CL - Cile 18
KE - Kenya 18
KR - Corea 18
TN - Tunisia 17
RO - Romania 16
IR - Iran 15
UY - Uruguay 15
EG - Egitto 14
NL - Olanda 14
LT - Lituania 13
DO - Repubblica Dominicana 12
IL - Israele 12
SA - Arabia Saudita 12
JM - Giamaica 11
EU - Europa 10
HN - Honduras 10
PA - Panama 10
PE - Perù 10
BO - Bolivia 9
CR - Costa Rica 9
GE - Georgia 9
OM - Oman 8
SN - Senegal 8
BG - Bulgaria 7
KZ - Kazakistan 6
PS - Palestinian Territory 6
RS - Serbia 6
AL - Albania 5
BH - Bahrain 5
BY - Bielorussia 5
LB - Libano 5
NG - Nigeria 5
NI - Nicaragua 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
BN - Brunei Darussalam 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
DK - Danimarca 3
IE - Irlanda 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BS - Bahamas 2
BW - Botswana 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
LU - Lussemburgo 2
MN - Mongolia 2
MY - Malesia 2
Totale 20.625
Salva come PNG Salva come JPEG
Città #
Dallas 2.960
Chandler 1.428
Singapore 1.357
Jacksonville 526
Hong Kong 514
Princeton 377
Beijing 326
Ashburn 304
São Paulo 221
Nanjing 219
Wilmington 169
Sassari 168
Ann Arbor 162
Dearborn 148
Shanghai 133
Rio de Janeiro 113
New York 107
Boardman 106
Los Angeles 106
Belo Horizonte 84
Santa Clara 84
Nanchang 78
Ho Chi Minh City 74
The Dalles 69
Columbus 61
Brasília 55
Munich 55
Woodbridge 54
Shenyang 53
Tianjin 53
Council Bluffs 52
Brussels 50
Changsha 48
Hebei 46
Tashkent 42
Toronto 42
Helsinki 41
Campinas 40
Nuremberg 40
Porto Alegre 40
Hanoi 39
Jinan 38
Warsaw 37
Ribeirão Preto 36
Brno 35
Curitiba 35
Jiaxing 35
Tokyo 34
San Francisco 33
Montreal 32
Norwalk 32
Buffalo 31
Izmir 31
Baghdad 30
Salvador 30
Andover 29
Falls Church 29
Guarulhos 28
Mountain View 28
San Jose 28
Goiânia 25
Guangzhou 25
Atlanta 24
Orem 24
Brooklyn 23
Campo Grande 23
Hangzhou 23
Houston 23
Algiers 22
Denver 22
Guayaquil 22
London 22
Ningbo 22
Stockholm 22
Kunming 21
Boston 20
Betim 19
Fortaleza 19
Johannesburg 19
Lahore 19
Quito 19
Zhengzhou 19
Chennai 18
Joinville 18
Mexico City 18
Praia Grande 18
São Bernardo do Campo 18
Baku 17
Casablanca 17
Contagem 17
Seoul 17
Sorocaba 17
Amman 16
Aracaju 16
Caxias do Sul 16
Frankfurt am Main 16
Juiz de Fora 16
Manaus 16
Osasco 16
Poplar 16
Totale 12.035
Salva come PNG Salva come JPEG
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 328
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 207
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 188
Aberrant fucosylation sustains the NOTCH and EGFR/NF-kB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma 185
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 184
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice. 172
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 170
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 170
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 166
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes 164
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade 164
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 162
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosomine in the resistant BFF1 rat strain 162
Activation of Beta-Catenin During Hepatocarcinogenesis in Transgenic Mouse Models: Relationships to Phenotype and Tumor Grade 162
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 162
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 160
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 160
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumor formation in mice via AKT2/mTORC1 cascade. 158
Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital 156
An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling 155
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells 153
Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis 152
Activation of the canonical Wnt/Beta-catenin pathway confers growth advantages in c-My/E2F1 transgenic mouse model of liver cancer 150
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma 148
AKT/mTOR activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis. 147
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 147
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver 146
[11C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice. 145
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. 142
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 142
Experimental models to define the genetic predisposition to liver cancer 141
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 140
Accomplices in crime: The diabolical liaison between protein tyrosine phosphatase 1B and ras in hepatocellular carcinoma 137
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 136
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice 136
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 136
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 134
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 133
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 132
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 131
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models 130
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma 130
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells 130
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans 130
Hydrodynamic transfection for generation of novel mouse models for liver cancer research. 128
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 125
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 124
Combined treatment with MEK and mTOR inhibitors is effective in in Vitro and in Vivo models of hepatocellular carcinoma 124
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 124
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 121
Application of comparative functional genomics to identify best-fit mouse models to study human cancer 120
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 118
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 118
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 117
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC 117
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 116
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 116
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 115
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma 115
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 115
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 115
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 114
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development 114
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer 113
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 111
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 111
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 109
Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis. 109
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 109
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 107
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma 106
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 106
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 106
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 105
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations 105
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 104
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma? 104
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. 104
A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors 103
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 103
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 103
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide 102
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer 101
Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats 101
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53 100
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma 100
Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma. 99
Non-functioning gastroenteropancreatic (GEP) tumors: a 111In-Pentetreotide SPECT/CT diagnostic study. 99
The dark side of the moon: AKT as a tumor suppressor in the liver? 98
Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma 97
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 95
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis 94
The warburg effect 97 years after its discovery 94
Beta catenin or genomic instability define two categories of liver cancer in transgenic mice 93
Classification and survival prediction of hepatocellular carcinoma by gene expression profiling 93
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 93
Comparison of liver oncogenic potential among human RAS isoforms 93
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade 93
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men. 93
Sulfatase 1: A new Jekyll and Hyde in hepatocellular carcinoma? 92
Totale 12.887
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021900 0 0 0 0 0 101 189 8 225 215 134 28
2021/20221.077 125 9 6 10 23 36 53 65 110 55 122 463
2022/20232.421 255 222 143 409 195 384 3 248 376 10 94 82
2023/2024557 116 37 16 25 103 25 3 57 0 12 48 115
2024/20256.457 43 52 366 170 314 223 546 1.131 2.275 868 295 174
2025/20266.541 426 2.069 1.569 1.111 922 444 0 0 0 0 0 0
Totale 20.890